IPCA Laboratories posts Rs. 130.23 crores consolidated profit in Q4FY22

The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer

For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore

IPCA Labs reports Q1FY22 net at Rs 306.66 Cr

Total income grew in the quarter

IPCA Laboratories increases stake in Trophic Wellness to 52.35%

With the acquisition of these further shares, TWPL has now become company's subsidiary.

IPCA Q4FY21 consolidated net profit slides QoQ to Rs. 161.34 Cr

The company has posted net profit of Rs.1140.01 crores during FY 2020-21

Cipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer

Dr. Kathiresan Rajasekar appointed President – International Business, Gufic Biosciences

With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader

Indian Pharma Market slips for third month in a row: Anand Rathi

According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)

Normalised quarter with impending margin pressure: ICICI Direct

ICICI Direct gives a preview on the earnings narrative for Q3FY22

Domestic growth to the fore as US weakness persists: ICICI Direct

ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report